Biodesix Inc (BDSX) stock news · rev $88.5M
Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.
This BDSX news page leads with what Biodesix Inc filed — not a scraped headline mill.
No cached 8-K sentence for BDSX yet. We will not pad this page with generic market recap.
Latest reported BDSX revenue for 2025-12-31 was $88.5M. Net income was -$35.3M. Revenue was up 24.1% from 2024-12-31 to 2025-12-31. BDSX currently screens at market cap $157.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BDSX stock page; for the tape open the quote page.
BDSX stock news FAQ
What are BDSX's latest revenue and net income?
Latest cached Biodesix Inc (BDSX) revenue for Dec 31, 2025 was $88.5M. Net income was -$35.3M. Statements: https://lician.com/financials/bdsx
How did BDSX revenue change from the prior cached period?
Cached Biodesix Inc (BDSX) revenue was up 24.1% from $71.3M (Dec 31, 2024) to $88.5M (Dec 31, 2025). Statements: https://lician.com/financials/bdsx
What is BDSX's market cap?
Biodesix Inc (BDSX) market cap is $157.6M on the latest cached fundamentals snapshot.
What kind of company is BDSX?
Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.
Where is BDSX stock news listed?
Cached stock news for Biodesix Inc (BDSX) is listed at https://lician.com/news/bdsx. Filings: https://lician.com/sec/bdsx
Not investment advice.